Losartan Market

Losartan Market Size, Share & Industry Analysis, By Application (Hypertension Treatment, Diabetic Nephropathy, Heart Failure Management, Left Ventricular Hypertrophy, Chronic Kidney Disease), By Formulation Type (Tablets, Capsules, Oral Suspensions, Extended-Release Formulations, Combination Drug Formulations), Key End-Use Industry (Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Research & Development Centers, Hospitals & Clinics, Online & Retail Pharmacies), and Forecast, 2025–2035

The global Losartan market is projected to grow steadily between 2025 and 2035, with a CAGR of 5.5%. This growth is primarily driven by the increasing prevalence of hypertension and related cardiovascular conditions, coupled with the widespread adoption of Losartan in treatment protocols. The demand for Losartan is further driven by its effectiveness in managing chronic kidney diseases and its role in combination therapies for various cardiovascular ailments.

Regionally, North America holds a significant share of the Losartan market, attributed to its advanced healthcare infrastructure and high prevalence of hypertension. Europe follows closely, supported by robust healthcare systems and a growing elderly population. The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare awareness, increasing incidences of hypertension, and expanding pharmaceutical manufacturing capabilities in countries like India and China.

The Losartan market report delves into the challenges such as regulatory complexities, pricing pressures, and competition from alternative treatments. However, the growing global focus on effective hypertension management and the increasing availability of Losartan in developing regions are expected to drive sustained growth in the market throughout the forecast period.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Losartan
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Application
    • Hypertension Treatment
    • Diabetic Nephropathy
    • Heart Failure Management
    • Left Ventricular Hypertrophy
    • Chronic Kidney Disease​
  • By Formulation Type
    • Tablets
    • Capsules
    • Oral Suspensions
    • Extended-Release Formulations
    • Combination Drug Formulations
  • Key End-Use Industries
    • Pharmaceutical Companies
    • Contract Manufacturing Organizations (CMOs)
    • Research & Development Centers
    • Hospitals & Clinics
    • Online & Retail Pharmacies

 

  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America and Middle East and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Losartan?
Losartan is an angiotensin II receptor blocker (ARB) primarily used to treat high blood pressure and protect the kidneys from damage due to diabetes. It is also prescribed for heart failure and to reduce the risk of strokes in patients with cardiovascular risk. Losartan works by relaxing blood vessels, allowing for smoother blood flow and reduced blood pressure.
What is the market size for Losartan?
The Losartan market is projected to grow steadily between 2025 and 2035 at a CAGR of 5.5%. This growth is driven by the rising global prevalence of hypertension and cardiovascular disorders. Increasing use of generic formulations and inclusion in essential medicine lists further contribute to its expanding market.
What are the drivers for the Losartan Market?
Key drivers include the growing incidence of hypertension, aging populations, and increasing awareness of cardiovascular health. The demand for cost-effective treatments and the widespread use of Losartan in both monotherapy and combination therapy further propel market growth.
Who are the key players operating in the Losartan Market?
Major players include Teva Pharmaceutical Industries, Mylan N.V., Torrent Pharmaceuticals, Aurobindo Pharma, Lupin Limited, Zhejiang Huahai Pharmaceutical, and Macleods Pharmaceuticals.
Which region would exhibit the fastest growth in the Losartan Market?
The Asia-Pacific region is expected to experience the fastest growth in the Losartan markets, driven by increasing healthcare investments, rising prevalence of hypertension, and expanding pharmaceutical production in countries like India and China.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.